2.37
price up icon10.23%   0.22
 
loading
前日終値:
$2.15
開ける:
$2.25
24時間の取引高:
16,750
Relative Volume:
0.03
時価総額:
$6.01M
収益:
-
当期純損益:
$-9.64M
株価収益率:
-0.3423
EPS:
-6.9236
ネットキャッシュフロー:
$-10.11M
1週間 パフォーマンス:
+0.42%
1か月 パフォーマンス:
-0.42%
6か月 パフォーマンス:
+6.76%
1年 パフォーマンス:
-45.01%
1日の値動き範囲:
Value
$2.1006
$2.37
1週間の範囲:
Value
$2.1006
$2.50
52週間の値動き範囲:
Value
$1.72
$10.66

Gt Biopharma Inc Stock (GTBP) Company Profile

Name
名前
Gt Biopharma Inc
Name
セクター
Healthcare (1165)
Name
電話
(800) 304-9888
Name
住所
315 MONTGOMERY STREET, SAN FRANCISCO
Name
職員
1
Name
Twitter
Name
次回の収益日
2024-12-08
Name
最新のSEC提出書
Name
GTBP's Discussions on Twitter

GTBP を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
0.2846 0 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1801 380.07M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.64 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.38 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
3.75 161.48M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
9.45 123.51M 0 0 0 0.00

Gt Biopharma Inc Stock (GTBP) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-12-02 開始されました ROTH MKM Buy
2021-05-24 開始されました H.C. Wainwright Buy
2021-04-13 開始されました B. Riley Securities Buy
2021-03-17 開始されました ROTH Capital Buy

Gt Biopharma Inc (GTBP) 最新ニュース

pulisher
Mar 28, 2025

Biotech Stocks Are Tumbling — But The Top 5 Are Standouts - Investor's Business Daily

Mar 28, 2025
pulisher
Mar 24, 2025

North American Morning Briefing : Stock Futures -2- - MarketScreener

Mar 24, 2025
pulisher
Mar 18, 2025

GT Biopharma (GTBP) Projected to Post Quarterly Earnings on Tuesday - Defense World

Mar 18, 2025
pulisher
Mar 17, 2025

Nanobodies Market Detailed In New Research Report 2025 | Sanofi, - openPR

Mar 17, 2025
pulisher
Mar 04, 2025

GT Biopharma to Participate in the 10th Anniversary of the Innate Killer Summit - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

Can GT Biopharma's TriKE® Technology Transform Blood Cancer Treatment? Phase 1 Trial Updates Coming in 2025 - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

GT Biopharma Launches Shareholder Communications Initiative - ACCESS Newswire

Mar 03, 2025
pulisher
Mar 01, 2025

Roth Capital Has Weak Forecast for GT Biopharma Q1 Earnings - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Analysts Issue Forecasts for GT Biopharma FY2029 Earnings - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

GT Biopharma Announces Dosing Of New Patient In GTB-3550 TriKE(TM) Phase I/II Clinical Trial - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

GT Biopharma Announces $7.1 Million Convertible Debt Financing - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

GT Biopharma Retail Chatter Soars Most Among Biotechs After Financing Strategy Tweak - Asianet Newsable

Feb 27, 2025
pulisher
Feb 25, 2025

GT Biopharma Announces Exercise of Warrants - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

"Signal Advance, Inc. (OTC: SIGL) Achieves Technology - openPR

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma announces warrant exercise, plans new offering - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma announces warrant exercise, plans new offering By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

GTBPGt Biopharma Inc Latest Stock News & Market Updates - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Stock market today: Wah Fu Education Group +219.55%, Jet.AI +46.26% among top gainers in early trading - Business Upturn

Feb 25, 2025
pulisher
Feb 25, 2025

Artificial Intelligence (AI) News Live Feed - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma withdraws SEC registration statement - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma Announces Request for Withdrawal of Form S-1 Registration Statement - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

GT Biopharma Pulls Back S-1 Filing: What Does This Mean for Their Financing Strategy? - StockTitan

Feb 25, 2025
pulisher
Feb 21, 2025

GT Biopharma, Inc. SEC 10-K Report - TradingView

Feb 21, 2025
pulisher
Feb 19, 2025

This New Nasdaq Biotech Could Revolutionize Emergency Cardiac CareHere's Why - StockTitan

Feb 19, 2025
pulisher
Feb 19, 2025

Short Interest in GT Biopharma, Inc. (NASDAQ:GTBP) Expands By 5.1% - Defense World

Feb 19, 2025
pulisher
Feb 15, 2025

Loss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Set To Breakeven - Yahoo Finance

Feb 15, 2025
pulisher
Feb 06, 2025

GT Biopharma Announces Recently Presented Data on Our Next Generation TriKE (OXS-C3550) at The Ash Meeting in Atlanta, GA - ACCESS Newswire

Feb 06, 2025
pulisher
Feb 05, 2025

Nanobodies Market Analysis: Growth Drivers in Targeted - openPR

Feb 05, 2025
pulisher
Feb 04, 2025

Pre-market Movers In Healthcare Sector: HUGE, ONTX, SVRA, CELC, CHFS... - RTTNews

Feb 04, 2025
pulisher
Jan 29, 2025

StockNews.com Initiates Coverage on Beasley Broadcast Group (NASDAQ:BBGI) - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

StockNews.com Begins Coverage on Ayala Pharmaceuticals (NASDAQ:ADXS) - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Barnes Group (NYSE:B) Now Covered by StockNews.com - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Apollo Commercial Real Estate Finance (NYSE:ARI) Stock Rating Lowered by StockNews.com - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

KULR Technology Group Announces Strategic Partnership with EDOM Technology - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

StockNews.com Begins Coverage on Power REIT (NYSE:PW) - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Embrace Change Acquisition Corp. Enters Definitive Merger Agreement with Tianji for Public ListingSAN DIEGO, CA – January 27, 2025 – Embrace Change Acquisition Corp. (NASDAQ: EMCGU), a special purpose acquisition company, and Tianji Tire Global - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Goldman Sachs Announces Adoption of Tax Benefit Preservation Plan - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

First Financial Bancorp Reports Solid Financial Performance in Fourth Quarter 2024 - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Seaport Res Ptn Forecasts Weaker Earnings for Sands China - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Galectin Therapeutics Inc. Reports Results from 2024 Annual Meeting in Recent 8-K Filing - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

Cormark Weighs in on Real Matters’ FY2025 Earnings (TSE:REA) - Defense World

Jan 29, 2025
pulisher
Jan 29, 2025

AmpliTech Group, Inc. (NASDAQ:AMPG) Short Interest Down 60.9% in January - Defense World

Jan 29, 2025
pulisher
Jan 28, 2025

GT Biopharma Announces First Patient Dosed in Phase 1 Trial - GlobeNewswire

Jan 28, 2025
pulisher
Jan 27, 2025

GT Biopharma Announces Expanded TriKE(TM) Partnership With Cytovance Biologics - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 27, 2025

GT Biopharma, Inc. Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies - Marketscreener.com

Jan 27, 2025
pulisher
Jan 27, 2025

GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-3650, Second-Generation TriKE for the Treatment of Hematologic Malignancies - The Manila Times

Jan 27, 2025
pulisher
Jan 27, 2025

GT Biopharma Initiates Phase 1 Trial of Advanced TriKE Therapy for Blood Cancers - StockTitan

Jan 27, 2025
pulisher
Jan 26, 2025

GT Biopharma Provides Update Concerning Trike(TM) Drug Development Programs and Other Strategic Initiatives - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 26, 2025

GT Biopharma Announces Completion of $5.6 Million Bridge Financing - ACCESS Newswire

Jan 26, 2025
pulisher
Jan 26, 2025

GT Biopharma Announces Dr. Greg Berk, M.D. Joins Board of Directors - ACCESS Newswire

Jan 26, 2025

Gt Biopharma Inc (GTBP) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.94
price down icon 3.89%
$72.00
price down icon 5.62%
$31.17
price up icon 0.13%
$18.80
price down icon 2.54%
$90.29
price down icon 0.85%
biotechnology ONC
$271.04
price down icon 0.42%
大文字化:     |  ボリューム (24 時間):